Helixgate

Helixgate

Uncategorized

Design of the biosensor-dependent coupling system stabilizes the high-synthesis phenotype of cell factory

Published

on

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Ideaya’s uveal melanoma drug exceeds success benchmark in late-stage trial

Ideaya’s uveal melanoma drug exceeds success benchmark in late-stage trial

Published

on

Ideaya’s late-stage data for a rare eye cancer drug has passed the company’s benchmark for success, bolstering expectations for a planned accelerated filing in the US.

The open-label Phase 2/3 uveal melanoma trial tested the …​ ​Read More

Continue Reading

Uncategorized

Seaport, Hemab set sail for Nasdaq

Published

on

Analysts are cautiously optimistic about an IPO rebound for biopharma. BioSpace is keeping track of companies that seek to trade on the public markets this year.

Continue Reading

Uncategorized

Rethinking dermatology trial design for late-stage success

A smarter approach to dermatology trials—built for durability and real-world impact.

Read More

Published

on

A smarter approach to dermatology trials—built for durability and real-world impact.

Read More

Continue Reading
Advertisement

Trending